Abstract: Retinoblastoma protein-interacting zinc finger gene RIZ encodes two different protein products, RIZ1 and RIZ2. Observations suggest that RIZ1 is a tumor suppressor, while RIZ2 acts as a negative regulator of RIZ1 and may play a positive role in oncogenesis. The imbalance amount of RIZ1 and RIZ2 may be involved in cancer development. In this study we detected the expression levels of RIZ1 and RIZ2 mRNA in human esophageal squamous cell carcinoma (ESCC) tissue specimens, reexpressed RIZ1 in the human ESCC cell line EC109 in which RIZ1 mRNA level was not detected, examined the changes of RIZ1 and RIZ2 mRNA expression, investigated the changes of proliferation, and apoptosis of the cells. We found that RIZ1 mRNA expression is commonly decreased or at undetectable level in human esophageal squamous cancer tissue specimens compared to the normal tissue specimens, while RIZ2 is usually expressed. With the forced expression of RIZ1, RIZ2 mRNA expression did not change, The ESCC cell proliferation was inhibited and apoptosis was induced. This unusual yinyang fashion of RIZ1/RIZ2 may contribute to the progression of ESCC.
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Methods

Tissues and Cell line culture
Carcinoma and corresponding normal tissue (> 5 cm from the edge of tumor) specimens were obtained from 25 patients with ESCC, confirmed by pathological tests in our department. The specimens were frozen in liquid nitrogen immediately after resection and stored at -80˚C for further studies. None of the patients in this study had received radiation therapy or chemotherapy before surgery.
Human esophageal squamous carcinoma cell line EC109 was purchased from ATCC (Rockville, MD, USA), incubated in RPMI1640 medium (Gibco-BRL, Carlsbad, CA, USA), supplemented with 10% new-born bovine serum (Gibco-BRL, Carlsbad, CA, USA), 2 mM 1 × L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (Life Technologies, Carlsbad, CA, USA), and maintained at 37°C in a humidified incubator with 5% CO 2 .
MSP
Genomic DNA was extracted from the ESCC cell line EC109 using TIANamp Genomic DNA Kit (TIANGEN, Beijing, PRC) and anultraviolet spectrophotometer was used to detect the purity and the amount. 20 μg gDNA was modified with bisulfite according to the manufacturer's protocols of EpiTect Fast DNA Bisulfite Kit (Qiagen, Hilden, GER), Methylation specific polymerase chain reaction (MSP) was used to detect the promoter region aberrant methylation of RIZ1 with respectively primers for methylated DNA (forward 5'-GTGGTGGT TATTGGGCGACGGC -3'; reverse 5'-GCTATTTCGCC GACCCCGACG -3') , and unmethylated DNA (forward 5'-TGGTGGTTATTGGGTGATGGT-3'; reverse 5'-ACTATTTCACCAACCCCAAGA-3'), the expected amplified fragments were 177 bp and 175 bp respectively. PCR conditions were as follows: 40 cycles of denaturation at 94°C for 30 seconds, annealing for methylation-specific amplification at 68°C or for unmethylation-specific at 60°C for 45 seconds, amplification at 72°C for 60 seconds, and finally extension at 72°C for 10 min. Agarose gel electrophoresis was used to analyze the PCR products.
Real time-PCR analysis
EC109 cells were cultured in 6-well plates and treated with 10 μmol/L 5-Aza-CdR (Sigma) for 72 h. The control group was routinely cultured without drugs. Then the cells were harvested for the next studies. Total RNA of the tissues and the cells was isolated with Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocols. Ultraviolet spectrophotometer was used to detect the purity and the amount. Reverse transcribed 2 μg RNA using Reverse Transcriptase M-MLV (Takara Bio, Inc., Shiga, Japan), Ribonuclease inhibitor (Takara Bio, Inc., Shiga, Japan) and dNTP mixture (Takara Bio, Inc., Shiga, Japan), according to the manufacturer's protocols. The cDNA templates were used in the next RT-PCR. 0.75 μl cDNA was mixed with 5 μl 2 × SYBR Premix ExTaqTM (Takara Bio, Inc., Shiga, Japan). Two different sets of primers were used to amplify the first strand cDNA samples: one set (RP168 + RP217) was for RIZ1; RIZ2 transcripts cannot be differentiated from RIZ, so the other set which represents RIZ gene was (RP216 + RP217) for RIZ1+RIZ2. RP168 primer is located within exon 4 (5'-TGG CTG CGA TAT GTG AAT TG-3'). RP216 primer is located within exon 6 (5'-CAA CTG AAG ACA ACT GAG CCA GA-3'). RP217 primer is located in coding exon 7 (5'-CCT CTG AGC ACT CTT CAA GAGT-3'). The primers for GAPDH (forward 5'-GAAGGTGAAGGTCGGAGTC-3', reverse 5'-GGGTGGAATCATATTGGAAC -3') were used for the amplification in a Light Cycler (Roche) RT-PCR System according to the manufacturer's protocols. An initial denaturation step at 94°C for 5 minutes, followed by 45 cycles of denaturation at 95°C for 5 seconds, annealing at 59°C (RIZ1) and 55°C (RIZ1+RIZ2) for 20 seconds, extension at 72°C for 10 seconds and then the solubility temperature curve assay was performed. The expression level of RIZ1and RIZ1+RIZ2 gene mRNA in normal esophageal tissues was presented as 2 -averageΔΔCT × 100% compared to carcinoma, and the expression levels of RIZ1 and RIZ1+RIZ2 gene mRNA in EC109 after being treated with 5-Aza-CdR was also presented as 2 -averageΔΔCT × 100% compared to that in the cells routinely cultured without the drug. 
MTT assay
Flow cytometry
EC109 cells were seeded at 1 × 10 6 /well in 6-well plates. The cells were treated with 5-Aza-CdR at a concen tration of 1 μmol/L for 72 h. Then the cells were harvested, washed twice with cold PBS and then fixed in 70% ethanol overnight, the fixed cells were stained with propidium iodide (50 μg/ml) and RNaseA (100 mg/ml) for 3 h at 37°C in the dark., FACS flow cytometry was used to measure the cell apoptosis. The process was repeated three times. Results were analyzed using ModFit software. 
Statistical analysis
Results
Expression of RIZ1 and RIZ2 in ESCC carcinoma and corresponding normal tissue specimens
Real-time PCR analysis was used to examine the mRNA expression levels of RIZ1 and RIZ1 + RIZ2 in 40 pairs ESCC carcinoma and corresponding normal tissue specimens. The results showed that the expression level of RIZ1 mRNA in esophageal carcinoma tissue specimens had reduced while the expression levels of RIZ1 + RIZ2 mRNA in carcinoma and normal esophageal tissue specimens had no statistically significant change (Fig. 1). 
Methylation status of RIZ1 gene in EC109
Methylation specific PCR (MSP) was used to examine the RIZ1 promoter methylation status in human ESCC cell line EC109. Amplified fragments of 177 bp and 175 bp were expected for methylated (M) and unmethylated (U) DNA respectively. Aberrant promoter region methylation status of RIZ1 gene in EC109 was detected (Fig. 2) .
Imbalance amounts of RIZ1 and RIZ2 after the re-expression of RIZ1
EC109 was treated with the DNA methyltransferase inhibitor 5-Aza-CdR. Real-time PCR was used to analyze the expression levels of RIZ1 and RIZ1 + RIZ2 in EC109 cells after being treated with 5-Aza-CdR and that in the cells routinely cultured without the drug. Restored expression of RIZ1 was detected while RIZ1 + RIZ2 mRNA expression level had no statistically significant difference (Fig. 3) . 
The changes of proliferation and induce apoptosis
MTT assay results showed that the proliferation of ESCC cell line EC109 was inhibited after being treated with 5-Aza-CdR. The inhibition was enhanced with the tension of time (F = 562.055, p = 0.000) and the increasing of 5-Aza-CdR concentration (F = 324.998, p = 0.000) (Fig. 4) .
Flow cytometric analysis showed that the rate of apoptosis in EC109 after being treated with 5-Aza-CdR was higher than the cells routinely cultivated (Fig. 5) . 
Discussion
Esophageal cancer (EC) is one of the most common malignant tumors in the digestive system that seriously threatens human health. The incidence and mortality rate in China both rank first in the world and respectively rank the fifth and fourth in all malignant tumor pathological types [12] . Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma account for more than 90% of all the esophageal tumor pathological type [13] . Unlike western countries and the USA, the main pathological type in our country is squamous cell carcinoma [14] . ESCC usually has a long asymptomatic latency period in its early stage, most of the patients have been in middle-late stage when they come to the hospital. ESCC is easy to recurrence and metastasis in postoperative patients because of the lack of indicators with high sensitivity and specificity, so the treatment efficacy remains unsatisfactory. We need to explore new insights into the molecular mechanisms of tumorigenesis and progression. Several lines of observation indicated that RIZ1 and RIZ2 regulate cell division and function in an unusual yin-yang fashion, and this unusual yin-yang fashion of RIZ1/RIZ2 was involved in tumorigenesis and progression [10, 11, [15] [16] [17] . In this study we hypothesized that the unusual yin-yang fashion of RIZ1/RIZ2 may contribute to the progression of ESCC.
Tumorigenesis and progression of ESCC involve multiple factors, multiple genes, and multi-stage progress [18, 19] . Mutations or alterations in proto-oncogenes or tumor suppressor genes are usually linked to the progress. The mechanism involves genetics and epigenetics [20] . Promoter region aberrant methylation is an important epigenetic change in suppressor gene deletion. It usually takes place in the so-called CpG island, which is rich of cytosine and guanylic acid. Genes with inactivation due to high promoter region methylation are very sensitive to DNA methylation inhibitors and can be reversible [21] . RIZ1 was proved to be a tumor suppressor gene in ESCC in our previous studies, whereby RIZ1 was lowly expressed or deleted in ESCC tumor tissues and cell lines. Promoter region aberrant methylation serves as an important role [8, 22] . In this paper Real-time PCR was used to examine both the expression levels of RIZ1 and RIZ1 + RIZ2 mRNA in ESCC carcinoma and corresponding normal tissue specimens. RIZ2 is generated by an internal promoter and RIZ2 transcripts cannot be differentiated from RIZ1. We use RIZI + RIZ2 represents PCR products derived from the overlapped sequences. The results suggested that RIZ1 was decreased (t = -57.738, p = 0.000) while RIZ2 was uniformly present in ESCC carcinoma (t = -1.180, p = 0.249) compared with the corresponding normal tissue specimens. Promoter region high methylation status serves as an important mechanism in RIZ1 down regulation or deletion [8, 22] . In this study RIZ1 promoter region aberrant methylation was detected by MSP in ESCC cell line EC109. When EC109 was treated with DNA methyltransferase inhibitor 5-Aza-CdR, we found that RIZ1 was restored (p = 0.000) while the level of RIZ1 + RIZ2 mRNA expression did not change (p = 0.673). This phenomenon revealed that the imbalance amounts of RIZ1 and RIZ2 may be involved in esophageal squamous cell carcinoma. With the change of imbalance amounts of RIZ1 and RIZ2, MTT analysis revealed that the cell proliferation was inhibited in a timedependent manner. Flow cytometric analysis revealed that cell apoptosis was induced. This unusual yin-yang fashion of RIZ1/RIZ2 may reveal an important underlying mechanism in ESCC tumorigenesis and progression. It may represent a potential target of novel therapeutic strategies and medication design. However, whether RIZ2 works as a negative factor of RIZ1, and how to regulate the RIZ1 tumor suppressing activity, need further study.
